PCOS and Fertility: A Complete Guide to Understanding Polycystic Ovary Syndrome and Conceiving Successfully

Polycystic ovary syndrome (PCOS) is the most common hormonal disorder in women of reproductive age, affecting an estimated 8–13% of women globally — including a significant proportion of women in Hong Kong and across Asia. It is also the leading cause of anovulatory infertility. Yet many women with PCOS go on to conceive naturally or with targeted support, and the condition is among the most responsive to both lifestyle intervention and medical treatment in fertility medicine.

This guide provides a comprehensive, evidence-based overview of PCOS and fertility: what the condition involves, how it affects conception, and the range of approaches available to women in Hong Kong who want to optimise their reproductive outcomes.

What Is PCOS? Understanding the Syndrome

PCOS is a hormonal and metabolic disorder characterised by a cluster of features — not all of which need to be present for a diagnosis. The diagnostic standard internationally (including in Hong Kong) is the Rotterdam Criteria (2003), which requires two of the following three features:

1. Irregular or absent ovulation — manifesting as irregular, infrequent, or absent periods (oligomenorrhoea or amenorrhoea)
2. Clinical or biochemical signs of hyperandrogenism — excess androgen activity, presenting as acne, hirsutism (unwanted facial or body hair), or elevated testosterone/androstenedione on blood tests
3. Polycystic ovarian morphology on ultrasound — ovaries containing 20+ small follicles (antral follicles) per ovary, or increased ovarian volume

Despite the name, "polycystic" ovaries are not ovaries full of cysts. They are ovaries containing many small immature follicles that have not developed fully — a consequence of the underlying hormonal disruption rather than the cause.

The underlying drivers of PCOS are complex and not fully understood. The most widely accepted model involves insulin resistance as a central driver (present in 50–70% of PCOS cases), which stimulates the ovaries to overproduce androgens, disrupting follicular development and preventing the hormonal surge that triggers ovulation. Genetic factors play a significant role: PCOS runs in families, and first-degree relatives have substantially elevated risk.

PCOS phenotypes vary widely. Some women have predominantly metabolic features (insulin resistance, weight gain); others have predominantly androgenic features (acne, hirsutism) with normal weight; some have classic polycystic morphology on ultrasound but few other symptoms. This heterogeneity means that PCOS management is highly individualised.

How PCOS Affects Fertility

The primary fertility challenge in PCOS is irregular or absent ovulation. Without ovulation, there is no egg available for fertilisation — making natural conception impossible or unpredictable.

Women with PCOS may experience:

• Irregular cycles (varying by weeks between periods) — making fertile window prediction difficult
• Anovulatory cycles — cycles where menstruation occurs but no egg is released
• Multiple positive OPK readings — LH may be chronically elevated in PCOS, causing false-positive OPK results across multiple days without true ovulation
• Extended fertile window unpredictability — ovulation can occur at any point in an irregular cycle

However, it is important to note that PCOS is not infertility. Many women with PCOS do ovulate, albeit irregularly. With appropriate support — lifestyle modification, targeted supplementation, and when needed, fertility medications — the majority of women with PCOS can achieve pregnancy.

Research suggests that women with PCOS who do ovulate may have higher per-cycle miscarriage rates, potentially related to elevated androgens affecting egg quality or insulin resistance affecting uterine receptivity. Addressing these factors before conception may reduce pregnancy loss risk.

Lifestyle Interventions: The First-Line Approach

For women with PCOS, particularly those with overweight or metabolic features, lifestyle modification is the evidence-based first-line intervention for restoring ovulation — and it can be remarkably effective.

Weight loss and PCOS ovulation: Studies consistently show that even modest weight loss of 5–10% body weight significantly improves ovulatory function in women with PCOS. A 10% reduction in body weight has been associated with spontaneous resumption of ovulation in women who were previously anovulatory. The mechanism involves improved insulin sensitivity, reduced androgen production, and restoration of the hormonal milieu that supports normal follicular development.

Dietary approach for PCOS: The most evidence-supported dietary pattern for PCOS combines:

• Low glycaemic index (GI) carbohydrates — reducing the insulin response that drives androgen overproduction. Replace white rice, white bread, and sugary foods with oats, legumes, vegetables, and wholegrain alternatives.
• Anti-inflammatory foods — colourful vegetables, olive oil, omega-3-rich fish, berries, nuts. PCOS involves chronic low-grade inflammation that worsens insulin resistance.
• Adequate protein — protein improves satiety and blunts the insulin response to carbohydrates.
• Limited sugar and ultra-processed foods — these drive the insulin spikes most problematic in PCOS.

Exercise in PCOS: Both aerobic exercise and resistance training improve insulin sensitivity independently of weight loss. A meta-analysis found that exercise interventions significantly improved ovulation frequency, testosterone levels, and insulin sensitivity in women with PCOS. Consistency matters more than intensity: 150 minutes of moderate activity weekly is the evidence-based target.

Key Supplements for PCOS Fertility

Several nutritional supplements have robust evidence for improving ovulatory function, metabolic parameters, and fertility outcomes in PCOS:

Myo-Inositol and D-Chiro-Inositol: These are arguably the most evidence-supported supplements for PCOS fertility. Inositol compounds are involved in insulin signal transduction — they act as "second messengers" that help cells respond to insulin. Inositol deficiency or impaired inositol metabolism is thought to contribute to insulin resistance in PCOS.

Multiple randomised controlled trials show myo-inositol supplementation (typically 2–4g daily) restores ovulatory cycles, reduces testosterone, improves LH:FSH ratio, reduces fasting insulin, and improves oocyte quality in women with PCOS. The 40:1 myo-inositol to D-chiro-inositol ratio reflects physiological tissue concentrations and is the most commonly studied formulation.

A 2012 meta-analysis found that myo-inositol significantly reduced testosterone and improved insulin resistance in women with PCOS. A 2017 RCT found that myo-inositol was as effective as metformin at restoring ovulatory cycles, with fewer side effects.

Folate (Methylfolate): Essential for all women trying to conceive. Women with PCOS who also have the MTHFR gene variant (which affects folate metabolism) benefit particularly from the active methylated form (5-MTHF) rather than standard folic acid.

Vitamin D: Deficiency is particularly common in women with PCOS and is correlated with worse metabolic and hormonal parameters. Vitamin D supplementation in deficient women with PCOS has been shown to improve insulin sensitivity, cycle regularity, and hormone profiles.

N-Acetyl Cysteine (NAC): A precursor to glutathione (the body's master antioxidant), NAC has been studied in PCOS for improving insulin sensitivity and ovulatory function. Some trials have found it comparable to metformin at inducing ovulation.

Chromium: A trace mineral that enhances insulin action. Studies in women with PCOS show chromium supplementation (200mcg daily) modestly improves insulin sensitivity and testosterone levels.

Omega-3 fatty acids: Anti-inflammatory and associated with reduced androgen levels, improved insulin sensitivity, and improved lipid profile in PCOS. Particularly valuable for women with the inflammatory metabolic phenotype.

Medical Treatments for PCOS-Related Infertility

When lifestyle and supplements have been optimised and conception hasn't occurred, medical options are available and generally highly effective for PCOS:

Ovulation induction medications:

• Letrozole (Femara): Now considered first-line for ovulation induction in PCOS in most international guidelines, including the 2023 international PCOS guidelines. An aromatase inhibitor, letrozole is taken for 5 days early in the cycle and stimulates ovulation without the oestrogen-suppressing effects that can reduce uterine receptivity with clomiphene.
• Clomiphene citrate (Clomid): A selective oestrogen receptor modulator (SERM), historically first-line for PCOS ovulation induction. Still widely used and effective for many women (achieves ovulation in ~70–80% of cases), though letrozole has demonstrated higher live birth rates in PCOS in head-to-head trials.
• Metformin: An insulin sensitiser that improves ovulatory function in PCOS by reducing insulin and androgen levels. Often used in combination with letrozole or clomiphene, particularly in women with metabolic PCOS features. Also used during pregnancy in women with PCOS to reduce gestational diabetes risk.

Gonadotrophin injections: FSH injections (IUI or timed intercourse protocols) are used when oral ovulation induction fails. Require careful monitoring to avoid ovarian hyperstimulation syndrome (OHSS), to which women with PCOS are particularly susceptible due to their high antral follicle count.

IVF with ICSI: For women who do not respond to oral ovulation induction or in the context of additional infertility factors (male factor, tubal factor). Women with PCOS undergoing IVF have excellent egg yields but require careful stimulation protocols to minimise OHSS risk. Antagonist protocols with low stimulation, combined with freeze-all strategy and frozen embryo transfer (FET), are typically recommended.

Laparoscopic ovarian drilling (LOD): A surgical procedure in which the ovary is punctured multiple times to reduce androgen-producing tissue. Can restore ovulation in women who haven't responded to medications. Less commonly used now with advancement of medical protocols, but still available in refractory cases.

PCOS Monitoring and Tracking Strategies

Standard ovulation tracking methods require modification for women with PCOS:

OPKs in PCOS: Standard OPKs can be misleading in PCOS because LH is often chronically elevated, leading to multiple positive readings across a cycle without ovulation occurring. Advanced OPKs that quantify LH concentration (like Mira Fertility Monitor) rather than providing a binary positive/negative are more informative in PCOS, allowing you to identify the true LH surge peak.

BBT charting: Remains useful but must be interpreted over multiple cycles, as the LH-ovulation-BBT rise interval may be less predictable. Combining BBT with OPK data provides the most complete picture.

Ultrasound monitoring: For women on ovulation induction medications, serial transvaginal ultrasound monitoring is standard practice to track follicular development and identify the optimal timing for intercourse or trigger injection.

Frequently Asked Questions About PCOS and Fertility

Q: Can I get pregnant naturally with PCOS?
A: Yes. Many women with PCOS conceive naturally, particularly those with milder forms, those who address insulin resistance and weight, and those whose ovulation is irregular rather than absent. Optimising lifestyle and considering targeted supplements is the starting point.

Q: How long does it take to see ovulatory improvement with myo-inositol?
A: Most studies observe improvements in ovulatory frequency within 3–6 months of consistent supplementation. Some women report cycle improvement within the first 2–3 months.

Q: Is PCOS inherited?
A: PCOS has a strong genetic component. First-degree relatives (mothers, sisters, daughters) of women with PCOS have approximately a 50% elevated risk. Multiple genes are involved, and the expression depends on environmental factors including diet, weight, and activity level.

Q: Does PCOS go away after pregnancy?
A: PCOS doesn't disappear after pregnancy, but symptoms often change throughout life. Some women find PCOS symptoms improve significantly after pregnancy. Post-menopause, the hormonal features of PCOS diminish, though metabolic features may persist.

Q: Does the number of follicles on ultrasound predict how hard it will be to conceive?
A: Not directly. Having many antral follicles (polycystic morphology) actually indicates a higher egg reserve. The fertility challenge comes from whether ovulation is occurring regularly, not from follicle count per se.

Q: Is metformin safe during pregnancy?
A: Metformin continues to be used during pregnancy by some clinicians to reduce miscarriage and gestational diabetes risk in PCOS, but practice varies. Discuss the risk-benefit balance with your doctor before and during pregnancy.

Q: Can PCOS affect pregnancy outcomes?
A: Women with PCOS have modestly elevated risks of gestational diabetes, pregnancy-induced hypertension, and miscarriage compared to women without PCOS. These risks are reduced with good metabolic management before and during pregnancy. Most women with PCOS have healthy pregnancies and babies.

Q: I have PCOS and normal weight — do lifestyle changes still help?
A: Yes. Even lean women with PCOS benefit from an anti-inflammatory, low-GI dietary pattern, regular exercise, and targeted supplementation. Insulin resistance can be present in lean PCOS, and myo-inositol, vitamin D, and NAC have evidence in lean phenotypes as well.